大幸薬品株式会社 · Pharmaceutical · FY ends Dec
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | ROYAL BANK OF CANADA SINGAPORE BRANCH-CLIENT’S A/C | 3,852,765 | 7.67% | ¥1.1B | ¥12.7M |
| 2 | 日本マスタートラスト信託銀行株式会社 | 3,426,100 | 6.82% | ¥1.0B | ¥11.3M |
| 3 | Takashi Shibata | 3,330,431 | 6.63% | ¥993M | ¥11.0M |
| 4 | Hitoshi Shibata | 3,298,810 | 6.56% | ¥983M | ¥10.9M |
| 5 | NOMURA SINGAPORE LIMITEDCUSTOMER SEGREGATED A/C FJ-1309 | 3,185,900 | 6.34% | ¥950M | ¥10.5M |
| 6 | ZONGYI SOLAR POWER | 2,129,400 | 4.24% | ¥635M | ¥7.0M |
| 7 | 柴田 晃宏 | 1,899,445 | 3.78% | ¥566M | ¥6.3M |
| 8 | Kowa Co., Ltd. | 1,508,000 | 3.00% | ¥450M | ¥5.0M |
| 9 | 柴田 穣 | 1,336,054 | 2.66% | ¥398M | ¥4.4M |
| 10 | アース製薬株式会社 | 1,311,400 | 2.61% | ¥391M | ¥4.3M |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| Hitoshi Shibata | Chairman & Representative Director | 3,298,810 | ¥983M | — |
| Takashi Shibata | President & Representative Director | 3,330,431 | ¥993M | — |
| 橋本 昌司 | Senior Managing Director | 16,795 | ¥5.0M | — |
| 富永 俊秀 | Director | 3,000 | ¥894,300 | — |
| 土居 健人 | Director | — | — | — |
| 三輪 哲生 | Director | — | — | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Dec 2025 | ¥298 | ¥18.38 | 16.2x | ¥3.3 | 50,636,900 |
| FY ending Dec 2024 | ¥331 | ¥17.90 | 18.5x | — | 50,636,900 |
| FY ending Dec 2023 | ¥331 | ¥-76.25 | — | — | 50,436,900 |
| FY ending Dec 2022 | — | ¥-112.26 | — | — | 44,136,900 |